CH547785A - Verfahren zur herstellung von 2',3'(alpha)-tetrahydrofuran-2'spiro-17(6,7(alpha)-dihalogenmethylen-1,2(alpha)-methylen-4-androsten-3-on)-derivaten. - Google Patents

Verfahren zur herstellung von 2',3'(alpha)-tetrahydrofuran-2'spiro-17(6,7(alpha)-dihalogenmethylen-1,2(alpha)-methylen-4-androsten-3-on)-derivaten.

Info

Publication number
CH547785A
CH547785A CH327973A CH327973A CH547785A CH 547785 A CH547785 A CH 547785A CH 327973 A CH327973 A CH 327973A CH 327973 A CH327973 A CH 327973A CH 547785 A CH547785 A CH 547785A
Authority
CH
Switzerland
Prior art keywords
alpha
dihalogenmethylene
androstene
spiro
tetrahydrofuran
Prior art date
Application number
CH327973A
Other languages
German (de)
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH547785A publication Critical patent/CH547785A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH327973A 1969-05-14 1970-05-06 Verfahren zur herstellung von 2',3'(alpha)-tetrahydrofuran-2'spiro-17(6,7(alpha)-dihalogenmethylen-1,2(alpha)-methylen-4-androsten-3-on)-derivaten. CH547785A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82467269A 1969-05-14 1969-05-14
US2118370A 1970-03-19 1970-03-19

Publications (1)

Publication Number Publication Date
CH547785A true CH547785A (de) 1974-04-11

Family

ID=26694377

Family Applications (2)

Application Number Title Priority Date Filing Date
CH683870A CH547792A (de) 1969-05-14 1970-05-06 Verfahren zur herstellung von spiro-steroiden.
CH327973A CH547785A (de) 1969-05-14 1970-05-06 Verfahren zur herstellung von 2',3'(alpha)-tetrahydrofuran-2'spiro-17(6,7(alpha)-dihalogenmethylen-1,2(alpha)-methylen-4-androsten-3-on)-derivaten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH683870A CH547792A (de) 1969-05-14 1970-05-06 Verfahren zur herstellung von spiro-steroiden.

Country Status (17)

Country Link
JP (1) JPS532865B1 (xx)
AR (1) AR192305A1 (xx)
BE (1) BE750330A (xx)
CA (1) CA926385A (xx)
CH (2) CH547792A (xx)
CS (2) CS151551B2 (xx)
DE (1) DE2023450C3 (xx)
DK (3) DK126992B (xx)
FI (2) FI47355C (xx)
FR (1) FR2051526B1 (xx)
GB (1) GB1265444A (xx)
IE (1) IE34194B1 (xx)
IL (1) IL34431A (xx)
NL (1) NL168844C (xx)
NO (1) NO131131C (xx)
SE (2) SE386904B (xx)
YU (1) YU34052B (xx)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356677A (en) * 1966-04-05 1967-12-05 Syntex Corp 1alpha, 2alpha-and 6alpha, 7alpha-dihalomethylene androstenes

Also Published As

Publication number Publication date
DE2023450B2 (de) 1978-10-05
IE34194L (en) 1970-11-14
JPS532865B1 (xx) 1978-02-01
CA926385A (en) 1973-05-15
FI47355B (xx) 1973-07-31
GB1265444A (xx) 1972-03-01
DE2023450A1 (de) 1971-01-14
DK127880B (xx) 1974-01-28
SE366305B (xx) 1974-04-22
NL168844B (nl) 1981-12-16
NL168844C (nl) 1982-05-17
BE750330A (fr) 1970-11-13
FI47885B (xx) 1974-01-02
IL34431A0 (en) 1970-07-19
DE2023450C3 (de) 1979-05-31
AR192305A1 (es) 1973-02-14
DK127880C (da) 1974-06-10
CS151551B2 (xx) 1973-10-19
DK126992B (da) 1973-09-10
YU117670A (en) 1978-05-15
FR2051526B1 (xx) 1974-04-12
YU34052B (en) 1978-10-31
NO131131B (xx) 1974-12-30
FI47355C (fi) 1973-11-12
SE386904B (sv) 1976-08-23
NO131131C (xx) 1975-04-09
CS151552B2 (xx) 1973-10-19
NL7006474A (xx) 1970-11-17
DK127505B (da) 1973-11-19
FR2051526A1 (xx) 1971-04-09
FI47885C (fi) 1974-04-10
IL34431A (en) 1974-03-14
IE34194B1 (en) 1975-03-05
CH547792A (de) 1974-04-11

Similar Documents

Publication Publication Date Title
CH552608A (de) Verfahren zur herstellung von azaspiroalkandion-derivaten.
AT299142B (de) Verfahren zur Herstellung von 2,2-Dimethylpropandiol-(1,3)
CH546241A (de) Verfahren zur herstellung von 6,7-benzomorphanen.
CH580082A5 (de) Verfahren zur herstellung von 2,4-diamino-5-benzylpyrimidinen.
CH546805A (de) Verfahren zur herstellung von polyphenylenoxyden.
CH549029A (de) Verfahren zur herstellung von dihydrobenzodiazepinonen.
CH548972A (de) Verfahren zur herstellung von norbornylderivaten.
CH547290A (de) Verfahren zur herstellung von nitro-imidazolderivaten.
CH511204A (de) Verfahren zur Herstellung von 4,4',4''-Trihydroxytriphenylmethylmethan
CH552593A (de) Verfahren zur herstellung von pyridinthioacetamidderivaten.
CH550177A (de) Verfahren zur herstellung von substituierten n-aminoalkyl-arylamino-imidazolinen-(2).
CH553181A (de) Verfahren zur herstellung von 4-heterosubstituierten azetidinonen-(2).
DE2021297B2 (de) Verfahren zur herstellung von 4,4'thio-bis-(2,6-di-tert.butylphenol)
CH557345A (de) Verfahren zur herstellung von tetrahydropyranolen.
CH542801A (de) Verfahren zur Herstellung von 1,1-Dihydroperfluoralkanolen
CH531523A (de) Verfahren zur Herstellung von 2,6-Dichlor-4-heterocyclyl-pyridin-3,5-dicarbonitrilen
CH547793A (de) Verfahren zur herstellung von neuen evomonosid-derivaten.
CH555801A (de) Verfahren zur herstellung von phenylaethanolamin-derivaten.
CH552601A (de) Verfahren zur herstellung von 4-amino-6,7,8-trialkoxychinazolinen.
CH547298A (de) Verfahren zur herstellung von pyrimidopyridazinen.
CH539015A (de) Verfahren zur Herstellung von 1,3-Diacetoxy-2-methylen-propan
CH550786A (de) Verfahren zur herstellung von 2,9-dioxatricyclo (4,3,1,0 3,7) decanonen.
CH548966A (de) Verfahren zur herstellung von 1,2-cycloalkyliden-3,5,6tri-o-benzyl-d-glucofuranosen.
CH524556A (de) Verfahren zur Herstellung von 2,3,6-Trimethylhydrochinon
CH549572A (de) Verfahren zur herstellung von substituierten dihydronormorphinonen.

Legal Events

Date Code Title Description
PL Patent ceased